Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-09-10

Clinical Trial Update: Safety & Efficacy of Intranasal Dexmedetomidine, Fentanyl & Midazolam in the Pediatric Emergency Room [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating intranasal dexmedetomidine, fentanyl, and midazolam for safety and efficacy in the pediatric emergency department was withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (intranasal) (dexmedetomidine)
  • FENTANYL (FENTANYL)
  • Midazolam (Midazolam)

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Acute Stress Disorder, Anxiety | Phase 2 | Status: WITHDRAWN